DrugJan 31, 2024
Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use recall — FDA D-0262-2024
Lack of Sterility Assurance: Aseptic process simulation failure.
Class IIFDA: TerminatedBE PHARMACEUTICALS AG
Recall history in this database
Classification mix: Class II: 2.
DrugSep 20, 2023
Pantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged recall — FDA D-1148-2023
Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
Class IIFDA: TerminatedBE PHARMACEUTICALS AG
Understanding this recall history
This page summarizes recall records in which the official source identifies BE PHARMACEUTICALS AG as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.